About Natrix Separations
Natrix Separations is a Healthcare company based in Darmstadt (Germany) founded in 2004, and was acquired by Merck Millipore in August 2017. Provider of proprietary filtration solutions for life science. Natrix Separations has raised $20.71 million across 4 funding rounds from investors including D. E. Shaw Group, Oxford Finance and Merck Millipore. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography.
Company details
Natrix separations specializes in developing single use and multi-cycle disposable chromatography products for downstream applications in biopharmaceutical manufacturing. Their proprietary Natrix HD Membranes offer features such as high functional binding group density, readily accessible functional groups, and multi-point molecular binding and thus help in overcoming efficiency, speed, and flexibility barriers which come with conventional chromatography approach. Their purification platform leverages the high binding capacity of resin-based chromatography with the high throughput and ease of use of traditional membrane adsorbers.
- Headquarters Darmstadt, Germany
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website natrixseparations.com
- Social LinkedIn Facebook
- Acquired by Merck Millipore (Aug 2017)
- Total Equity Funding$20.71M (USD)
in 4 rounds
- Latest Funding Round$8M (USD), Debt – Venture
Jul 2014
- InvestorsD. E. Shaw Group
& 4 more
- Acquired byMerck Millipore
(Aug 2017)
Funding Insights of Natrix Separations
Natrix Separations has successfully raised a total of $20.71M across 4 strategic funding rounds. The most recent funding activity was a Debt β Venture round of $8 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20.71M
- Total Rounds 4
- Last Round Debt – Venture β $8M
- First Round $1.71M
(Sep 2005)
- Investors Count 4
All 4 funding rounds of Natrix Separations with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2014 | $8M | Debt – Venture | β | β | |
| Aug 2012 | $990,000 | Debt – Conventional | β | β | |
| Sep 2008 | $19M | Series B | β | β | |
| Sep 2005 | $1.71M | Series A | β | β |
5 investors in total: 5 institutional.
Investors in Natrix Separations
Natrix Separations has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include D. E. Shaw Group, Oxford Finance and Merck Millipore.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
It serves as a government backed investment fund focused on the economic growth of southern ontorio. | 2009 | feddevontario.gc.ca | Waterloo, Canada | |
Multinational investment management services are provided globally. | 1988 | deshaw.com | New York, United States | |
Commercial banking services for small and medium-sized enterprises are provided. | 1944 | bdc.ca | Montreal, Canada | |
Provider of chemicals and solutions for life science research and industrial applications | 1954 | merckmillipore.com | Darmstadt, Germany |
Investor details for Natrix Separations
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Natrix Separations
4 dated milestones of Natrix Separations across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Natrix Separations is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Debt β Venture, of $8.0M.
- Exit Acquired by Merck Millipore.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Natrix Separations
Natrix Separations was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Natrix Separations is headquartered in Darmstadt, Germany. It is registered at Darmstadt, Hesse, Germany.
Natrix Separations is a funded company, having raised a total of $20.71M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1.71M, raised on Sep 2005.
Natrix separations specializes in developing single use and multi-cycle disposable chromatography products for downstream applications in biopharmaceutical manufacturing. Their proprietary Natrix HD Membranes offer features such as high functional binding group density, readily accessible functional groups, and multi-point molecular binding and thus help in overcoming efficiency, speed, and flexibility barriers which come with conventional chromatography approach. Their purification platform leverages the high binding capacity of resin-based chromatography with the high throughput and ease of use of traditional membrane adsorbers.
Natrix Separations has 5 investors. Key investors include D. E. Shaw Group, Oxford Finance, Merck Millipore, BDC, and FedDev Ontario.
Yes. Natrix Separations was acquired by Merck Millipore in August 2017.
